Kristi D. Viles, Ph.D.
Affiliations: | 2006 | Duke University, Durham, NC |
Area:
Molecular BiologyGoogle:
"Kristi Viles"Parents
Sign in to add mentorBruce A. Sullenger | grad student | 2006 | Duke | |
(Investigating the influence of proximity on trans -splicing in mammalian cells.) | ||||
Bruce A. Sullenger | post-doc | Duke |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ray P, Viles KD, Soule EE, et al. (2013) Application of aptamers for targeted therapeutics. Archivum Immunologiae Et Therapiae Experimentalis. 61: 255-71 |
Lawal NO, Viles KD, Barbas A, et al. (2013) Gene and MicroRNA Profiling of Radioresistant Pancreatic Cancer Cell Lines Journal of Surgical Research. 179: 193 |
Rialon K, Viles K, Barbas A, et al. (2012) In Vivo Selection of Aptamers Targeting Pancreatic Cancer Journal of Surgical Research. 172: 341 |
Barbas A, Viles K, Rialon K, et al. (2011) In-vivo SELEX Against Pancreatic Cancer Xenografts Journal of Surgical Research. 165: 307 |
White R, Singh S, Hsu S, et al. (2009) 54: Development of a Gene Expression Profile for Predicting Gemcitabine Response in Pancreatic Cancer Journal of Surgical Research. 151: 195 |
White RR, Roy JA, Viles KD, et al. (2008) A nuclease-resistant RNA aptamer specifically inhibits angiopoietin-1-mediated Tie2 activation and function. Angiogenesis. 11: 395-401 |
Viles KD, Sullenger BA. (2008) Proximity-dependent and proximity-independent trans-splicing in mammalian cells. Rna (New York, N.Y.). 14: 1081-94 |
Mi J, Zhang X, Rabbani ZN, et al. (2008) RNA aptamer-targeted inhibition of NF-kappa B suppresses non-small cell lung cancer resistance to doxorubicin. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 66-73 |
McNamara JO, Andrechek ER, Wang Y, et al. (2006) Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nature Biotechnology. 24: 1005-15 |